Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000437705

Medchemexpress LLC IK1 inhibitor PA-6 | 500715-03-7 | 99.3% | 492.61 | 50 MG
SDP

Catalog No. 5000437705
Encompass_Preferred

IK1 inhibitor PA-6, a pentamidine analogue, is a selective and potent IK1 (KIR2.x ion-channel-carried inward rectifier current) inhibitor. It has IC50 values of 12-15 nM for human and mouse KIR2.x currents and elevates KIR2.1 protein expression, inducing intracellular KIR2.1 accumulation. This inhibitor has the potential to treat atrial fibrillation and arrhythmia.

  • Selective and potent IK1 inhibitor
  • IC50 values of 12-15 nM for human and mouse KIR2.x currents
  • Elevates KIR2.1 protein expression
  • Induces intracellular KIR2.1 accumulation
  • Potential to treat atrial fibrillation
  • Potential to treat arrhythmia

Catalog No. 50-004-37705 Supplier Medchemexpress LLC Supplier No. HY11254450MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

IK1 inhibitor PA-6, a pentamidine analogue, is a selective and potent IK1 (KIR2.x ion-channel-carried inward rectifier current) inhibitor. It has IC50 values of 12-15 nM for human and mouse KIR2.x currents and elevates KIR2.1 protein expression, inducing intracellular KIR2.1 accumulation. This inhibitor has the potential to treat atrial fibrillation and arrhythmia.

  • Selective and potent IK1 inhibitor
  • IC50 values of 12-15 nM for human and mouse KIR2.x currents
  • Elevates KIR2.1 protein expression
  • Induces intracellular KIR2.1 accumulation
  • Potential to treat atrial fibrillation
  • Potential to treat arrhythmia

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.